April 8, 2019
OTITOPIC™ Pursues Additional New Indication for Dry Powder Inhalation of Aspirin as a Treatment for Non-Small-Cell Lung Cancer (NSCLC)
The new treatment can potentially provide benefits superior to other commontherapies greatly improving clinical outcomes for patients being treatedfor lung cancer.